236 related articles for article (PubMed ID: 9853178)
1. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.
Mehta JL
Clin Cardiol; 1998 Dec; 21(12):879-84. PubMed ID: 9853178
[TBL] [Abstract][Full Text] [Related]
2. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.
Cheng TO
Clin Cardiol; 1999 Jun; 22(6):A27. PubMed ID: 10376172
[No Abstract] [Full Text] [Related]
3. [Aspirin and prevention of cardiovascular risk].
Karila-Cohen D; Gabriel Steg P
Rev Med Interne; 2000 Mar; 21 Suppl 1():35s-40s. PubMed ID: 10763203
[TBL] [Abstract][Full Text] [Related]
4. What are all the things that aspirin does?
Flower R
BMJ; 2003 Sep; 327(7415):572-3. PubMed ID: 12969898
[No Abstract] [Full Text] [Related]
5. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
Hohlfeld T; Saxena A; Schrör K
Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase inhibition in patients with coronary artery disease.
Frishman WH
J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
[No Abstract] [Full Text] [Related]
7. Aspirin and its rivals. As your options increase, your choices get harder.
Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
[No Abstract] [Full Text] [Related]
8. Aspirin sensitivity: implications for patients with coronary artery disease.
Gollapudi RR; Teirstein PS; Stevenson DD; Simon RA
JAMA; 2004 Dec; 292(24):3017-23. PubMed ID: 15613671
[TBL] [Abstract][Full Text] [Related]
9. COX-2 selective NSAIDs.
Ryan NS
Cleve Clin J Med; 2000 Jan; 67(1):67. PubMed ID: 10645679
[No Abstract] [Full Text] [Related]
10. Aspirin and cyclooxygenase-2 inhibitors.
Armstrong TA
Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
[No Abstract] [Full Text] [Related]
11. Aspirin in the prevention of cardiovascular disease in women.
Schwartz DJ
N Engl J Med; 2005 Jun; 352(26):2751-2; author reply 2751-2. PubMed ID: 15987927
[No Abstract] [Full Text] [Related]
12. Aspirin resistance: does it exist and is it an important clinical problem?
Eikelboom J
Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
[No Abstract] [Full Text] [Related]
13. [A 100 years of aspirin: a drug with a future?].
Sánchez García P
An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
[No Abstract] [Full Text] [Related]
14. Cardioprotective effects of aspirin compromised by other NSAIDs.
Gottlieb S
BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958094
[No Abstract] [Full Text] [Related]
15. An international scientific meeting on aspirin is needed.
Morgan G
J Epidemiol Community Health; 2003 May; 57(5):314. PubMed ID: 12700207
[No Abstract] [Full Text] [Related]
16. How hot is inflammation in acute coronary syndrome?
Verheugt FW
Eur Heart J; 2000 Dec; 21(24):1990-2. PubMed ID: 11102246
[No Abstract] [Full Text] [Related]
17. Aspirin therapy for cardiovascular disease.
Goodnight SH
Curr Opin Hematol; 1996 Sep; 3(5):355-60. PubMed ID: 9372101
[TBL] [Abstract][Full Text] [Related]
18. [Aspirin. A wonder drug?].
Diez-Ewald M
Invest Clin; 1997 Jun; 38(2):59-61. PubMed ID: 9296640
[No Abstract] [Full Text] [Related]
19. Cardiovascular events and COX-2 inhibitors.
McGeer PL; McGeer EG; Yasojima K
JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735747
[No Abstract] [Full Text] [Related]
20. Aspirin: new cardiovascular uses for an old drug.
Patrono C
Am J Med; 2001 Jan; 110(1A):62S-65S. PubMed ID: 11166001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
